Sex Differences in Permanent Discontinuation of Trial Medication in Chronic Coronary Artery Disease: The LoDoCo2 Trial - Marte F. van der Bijl; Jenny van der Veen; Aernoud T.L. Fiolet; Eric Boersma; Jan H. Cornel; John W. Eikelboom; Stefan M. Nidorf; Peter L. Thompson; Jalina Jannink; Iris C.D. Westendorp; Arend Mosterd; Hester M. den den Ruijter; et al. (Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease)